OncBioMune Pharmaceuticals, Inc. Financials

Market Capitalization $8.67 Billion as of Feb. 1, 2022

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-1262.14
Forward PE
Price to Sales TTM	$15077.76
Price to Book MRQ	$-5919.15
Enterprise to Revenue	23977.04
Enterprise to EBITDA	-2677.21

Financial Reports as of Dec. 31, 2021

Financials

Fiscal Year Ends	2021-09-30
Most Recent Quarter	2021-12-31
Profit Margin	76.77%
Operating Margin	-928.24%
Return on Assets TTM	-142.13%
Return on Equity TTM	13.46%

Income Statement

Revenue TTM	$574,789
Revenue per Share TTM	$0.00
Quarterly Revenue Growth	706.70%
Gross Profit TTM	$256,679
EBITDA	$-5,147,800
Net Income to Common TTM	$-6,751,033
Diluted EPS TTM	$0.00
Quarterly Earnings Growth YoY	706.69%

Balance Sheet

Total Cash MRQ	$431,382
Total Cash per Share MRQ	$0.00
Total Debt MRQ	$
Total Debt to Equity MRQ	-0.03
Current Ratio MRQ	0.24
Book Value per Share MRQ	$0.00

Cash Flow

Operating Cash Flow TTM	$-5,128,749
Levered Free Cash Flow TTM	$-1,607,348

OBMP Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	5,555,469,824
Float Shares	455,437,689
Avg 10 Volume	56,512
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	91.80%
% Held by Institutions	0.00%

Stock Price Summary

Beta	26.28
Fifty Two Week Low	$0.05
Fifty Two Week High	$7.00
Fifty Two Week Change	-0.28%
Day 50 MA	$1.22
Day 200 MA	$1.06

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2019-09-12
Ex Dividend Date
Last Split Factor
Last Split Date	2019-09-12